Back to Search
Start Over
Transplantation strategies for patients with follicular lymphoma.
- Source :
-
Current opinion in hematology [Curr Opin Hematol] 2005 Jul; Vol. 12 (4), pp. 266-72. - Publication Year :
- 2005
-
Abstract
- Purpose of Review: This review summarizes the current status and new developments in autologous and allogeneic transplantation strategies for patients with follicular lymphoma including novel concepts of myeloablative radioimmunotherapy, allogeneic transplantation with dose-reduced conditioning, and in-vivo purging strategies using B-cell-specific antibodies.<br />Recent Findings: Substantial progress has been made in the clinical management of follicular lymphoma. Besides immunochemotherapeutic approaches combining the B-cell antibody rituximab with conventional chemotherapy regimens, myeloablative chemotherapy or radiochemotherapy supported by autologous peripheral blood stem cell transplantation has been shown to be a highly effective treatment for advanced-stage disease. Dose-reduced conditioning regimens followed by allogeneic transplantation have substantially reduced treatment-related mortality of this approach and ongoing studies are evaluating whether the therapeutic benefit outweighs morbidity and mortality of this potentially curative treatment. Emerging concepts include the use of rituximab for in-vivo purging before reinfusion of autologous stem cells or the application of myeloablative radioimmunotherapy as part of myeloablative consolidation.<br />Summary: The data on myeloablative therapy followed by autologous stem cell transplantation or allogeneic transplantation are encouraging. Allogeneic transplantation with dose-reduced conditioning should be further evaluated within clinical trials, however, in particular for patients with relapsed or refractory lymphoma. Future prospective randomized clinical trials should reevaluate the role of autologous stem cell transplantation in the era of antibody-based therapy and define the role of radioimmunotherapy and of reduced-intensity allogeneic transplantation.
- Subjects :
- Antibodies, Monoclonal therapeutic use
Antibodies, Monoclonal, Murine-Derived
Clinical Trials as Topic
Combined Modality Therapy
Humans
Lymphoma, Follicular immunology
Rituximab
Transplantation Conditioning
Transplantation, Autologous
Transplantation, Homologous
Hematopoietic Stem Cell Transplantation
Lymphoma, Follicular therapy
Radioimmunotherapy
Subjects
Details
- Language :
- English
- ISSN :
- 1065-6251
- Volume :
- 12
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Current opinion in hematology
- Publication Type :
- Academic Journal
- Accession number :
- 15928482
- Full Text :
- https://doi.org/10.1097/01.moh.0000166499.72138.57